Palazestrant, CAS [[2092925-89-6]]

Produktübersicht

• Artikelname: Palazestrant, CAS [[2092925-89-6]]
• Artikelnummer: MCE-HY-148789
• Hersteller Artikelnummer: HY-148789
• Alternativnummer: MCE-HY-148789-500MG,MCE-HY-148789-25MG,MCE-HY-148789-1MG,MCE-HY-148789-1G,MCE-HY-148789-100MG,MCE-HY-148789-10MMX1ML,MCE-HY-148789-5MG,MCE-HY-148789-10MG,MCE-HY-148789-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: OP-1250

Produktbeschreibung

Palazestrant is an antiestrogen and antineoplastic agent. Palazestrant can completely inhibit the activity of 17b-estradiol (E2) with IC50 value of 6.4 nM, and inhibit the proliferation of MCF7 and CAMA-1 cells with IC50 value of 1.4-1.6 nM. Palazestrant can inhibit ER+/HER2+ cancer[1][2][3].

Produkteigenschaften

• Molekulargewicht: 449.60
• Reinheit: 99.90
• CAS Nummer: [2092925-89-6]
• Formel: C28H36FN3O
• Target-Kategorie: Estrogen Receptor/ERR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound